1-3 of 3
Abdullah Kutlar
Close
Sort by
Journal Articles

A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease

Clinical Trials & Observations
Jane S. Hankins, Donald Brambilla, Michael B. Potter, Abdullah Kutlar, Robert Gibson, Allison A. King, Ana A. Baumann, Cathy Melvin, Victor R. Gordeuk, Lewis L. Hsu, Chinonyelum Nwosu, Jerlym S. Porter, Nicole M. Alberts, Sherif M. Badawy, Jena Simon, Jeffrey A. Glassberg, Richard Lottenberg, Lisa DiMartino, Sara Jacobs, Maria E. Fernandez, Hayden B. Bosworth, Lisa M. Klesges, Nirmish Shah
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7190–7201.
https://doi.org/10.1182/bloodadvances.2023010670
Published: 2023
Includes: Supplemental data
Journal Articles

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease

Clinical Trials & Observations
Julie Kanter, R. Clark Brown, Cynthia Norris, Santosh M. Nair, Abdullah Kutlar, Deepa Manwani, Nirmish Shah, Chiaki Tanaka, Shankaranand Bodla, Gessami Sanchez-Olle, Urs Albers, Darla Liles
Journal: Blood Advances
Blood Adv (2023) 7 (6): 943–952.
https://doi.org/10.1182/bloodadvances.2022008209
Published: 2023
Includes: Multimedia, Supplemental data
Journal Articles

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain

Amanda M. Brandow, C. Patrick Carroll, Susan Creary, Ronisha Edwards-Elliott, Jeffrey Glassberg, Robert W. Hurley, Abdullah Kutlar, Mohamed Seisa, Jennifer Stinson, John J. Strouse, Fouza Yusuf, William Zempsky, Eddy Lang
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2656–2701.
https://doi.org/10.1182/bloodadvances.2020001851
Published: 2020
Includes: Supplemental data